Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MLEC Stock Forecast 2025-2026
$7.81
Current Price
$342.43M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MLEC Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
MLEC Price Momentum
-14.2%
1 Week Change
+1,000.0%
1 Month Change
+550.8%
1 Year Change
+876.3%
Year-to-Date Change
-25.4%
From 52W High of $10.47
+1,374.2%
From 52W Low of $0.53
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Moolec Science (MLEC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MLEC and similar high-potential opportunities.
Latest MLEC Stock Price Targets & Analyst Predictions
MLEC has shown a year-to-date change of 876.3% and a 1-year change of 550.8%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MLEC. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MLEC Analyst Ratings
1
Buy
0
Hold
0
Sell
MLEC Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $7.81
Latest MLEC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MLEC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 30, 2024 | Maxim Group | Anthony Vendetti | Buy | Initiates | $6.00 |
| Nov 22, 2022 | Cantor Fitzgerald | Overweight | Upgrade | $0.00 | |
| Oct 20, 2022 | HC Wainwright & Co. | Buy | Maintains | $0.00 | |
| Sep 26, 2022 | Wedbush | Outperform | Maintains | $0.00 | |
| Sep 7, 2022 | Capital One | Overweight | Initiates | $0.00 |
Moolec Science S.A. (MLEC) Competitors
The following stocks are similar to Moolec Science based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
MLEC
Moolec Science
mkt cap
36.40M
Moolec Science S.A. (MLEC) Financial Data
Moolec Science S.A. has a market capitalization of $342.43M with a P/E ratio of -41.1x. The company generates $7.83M in trailing twelve-month revenue with a -105.7% profit margin.
Revenue growth is +948.3% quarter-over-quarter, while maintaining an operating margin of -77.9% and return on equity of -174.7%.
Valuation Metrics
Market Cap
$342.43M
Enterprise Value
$54.40M
P/E Ratio
-41.1x
PEG Ratio
-35.7x
Price/Sales
43.7x
Growth & Margins
Revenue Growth (YoY)
+948.3%
Gross Margin
-25.5%
Operating Margin
-77.9%
Net Margin
-105.7%
EPS Growth
+948.3%
Financial Health
Cash/Price Ratio
+6.2%
Current Ratio
1.5x
Debt/Equity
789.7x
ROE
-174.7%
ROA
-21.7%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Moolec Science S.A. (MLEC) Business Model
About Moolec Science S.A.
What They Do
Biotechnology company innovating in plant-based proteins.
Business Model
Moolec Science S.A. uses molecular farming techniques to produce animal proteins from plant-based systems, generating revenue by providing sustainable protein alternatives to the food industry. Their products target the growing demand for ethical and environmentally friendly food options, appealing to consumers and businesses focused on sustainability.
Additional Information
The company’s approach not only aims to match the nutritional value and taste of traditional animal proteins but also addresses the environmental impact of protein production. By leveraging plants as bioreactors, Moolec Science contributes to reducing the ecological footprint of food production, aligning with global sustainability goals and trends in agriculture.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
52
CEO
Mr. Gaston Paladini M.B.A.
Country
Luxembourg
IPO Year
2023
Website
moolecscience.comMoolec Science S.A. (MLEC) Latest News & Analysis
Latest News
Quick Summary
Moolec Science SA announced a 1-for-10 reverse stock split, consolidating every ten shares into one. This decision follows shareholder and board resolutions from April 22, 2025.
Why It Matters
Moolec's 1-for-10 reverse stock split consolidates shares, potentially increasing their market price and improving perceptions of financial stability, influencing investor sentiment and trading activity.
Source: Accesswire
Market Sentiment:
Neutral
Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms
25 days ago
Quick Summary
Moolec Science SA (NASDAQ:MLEC) has signed a Business Combination Agreement to acquire Bioceres Group and related entities in an all-stock transaction, expanding its corporate structure.
Why It Matters
The merger could enhance Moolec's market position and growth potential by consolidating resources and expertise, affecting stock performance and investor sentiment.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Moolec Science SA (NASDAQ: MLEC) has received a notification from Nasdaq regarding non-compliance with listing rules due to its share price remaining below $1 for over 30 days.
Why It Matters
Moolec Science SA's non-compliance with Nasdaq's listing rules could lead to delisting, impacting its stock value and liquidity, which may deter investors.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Moolec Science SA (NASDAQ:MLEC) received USDA-APHIS regulatory clearance for its GE peas producing iron via bovine proteins, marking its third approval in 18 months for GE crops.
Why It Matters
Moolec Science SA's regulatory approvals for its genetically engineered peas enhance its product portfolio, potentially boosting market confidence and investment appeal in the biotech sector.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Moolec Science SA (NASDAQ:MLEC) reported a fourth-quarter update for FY 2024, highlighting an offtake agreement with a major CPG company and an R&D collaboration with Bunge.
Why It Matters
Moolec's offtake agreement with a major CPG food company and collaboration with Bunge could enhance revenue potential and innovation, positively impacting future growth prospects and investor sentiment.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Moolec Science SA (NASDAQ:MLEC) will hold its Q4 2024 earnings conference call on October 2, 2024, at 8:30 AM ET, featuring key company executives.
Why It Matters
Earnings calls provide insights into a company's financial health and strategic direction. Moolec Science's Q4 call may reveal key performance metrics and future plans impacting stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About MLEC Stock
What is Moolec Science S.A.'s (MLEC) stock forecast for 2025?
Analyst forecasts for Moolec Science S.A. (MLEC) are not currently available. The stock is trading at $7.81.
Is MLEC stock a good investment in 2025?
According to current analyst ratings, MLEC has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.81. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MLEC stock?
Price predictions from Wall Street analysts for MLEC are not currently available. The stock is trading at $7.81.
What is Moolec Science S.A.'s business model?
Moolec Science S.A. uses molecular farming techniques to produce animal proteins from plant-based systems, generating revenue by providing sustainable protein alternatives to the food industry. Their products target the growing demand for ethical and environmentally friendly food options, appealing to consumers and businesses focused on sustainability.
What is the highest forecasted price for MLEC Moolec Science S.A.?
Price targets from Wall Street analysts for MLEC are not currently available. The stock is trading at $7.81.
What is the lowest forecasted price for MLEC Moolec Science S.A.?
Price targets from Wall Street analysts for MLEC are not currently available. The stock is trading at $7.81.
What is the overall MLEC consensus from analysts for Moolec Science S.A.?
The overall analyst consensus for MLEC is bullish. Out of 2 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell.
How accurate are MLEC stock price projections?
Stock price projections, including those for Moolec Science S.A., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 16, 2025 9:15 AM UTC